Abstract. The mitochondrial matrix enzyme ornithine transcarbamylase (OTC) is synthesized on cytoplasmic polyribosomes as a precursor (pOTC) with an NH2-terminal extension of 32 amino acids. We report here that rat pOTC synthesized in vitro is internalized and cleaved by isolated rat liver mitochondria in two, temporally separate steps. In the first step, which is dependent upon an intact mitochondrial membrane potential, pOTC is translocated into mitochondria and cleaved by a matrix protease to a product designated iOTC, intermediate in size between pOTC and mature OTC. This product is in a trypsin-protected mitochondrial location. The same intermediate-sized OTC is produced in vivo in frog oocytes injected with in vitro-synthesized pOTC. The proteolytic processing of pOTC to iOTC involves the removal of 24 amino acids from the NH2 terminus of the precursor and utilizes a cleavage site two residues away from a critical arginine residue at position 23. In a second cleavage step, also catalyzed by a matrix protease, iOTC is converted to mature OTC by removal of the remaining eight residues of leader sequence.
mature OTC by removal of the remaining eight residues of leader sequence.
To define the critical regions in the OTC leader peptide required for these events, we have synthesized OTC precursors with alterations in the leader. Substitution of either an acidic (aspartate) or a "helix-breaking" (glycine) amino acid residue for arginine 23 of the leader inhibits formation of both iOTC and OTC, without affecting translocation. These mutant precursors are cleaved at an otherwise cryptic cleavage site between residues 16 and 17 of the leader. Interestingly, this cleavage occurs at a site two residues away from an arginine at position 15.
The data indicate that conversion of pOTC to mature OTC proceeds via the formation of a third discrete species: an intermediate-sized OTC. The data suggest further that, in the rat pOTC leader, the essential elements required for translocation differ from those necessary for correct cleavage to either iOTC or mature OTC.
M
ost mitochondrial proteins are encoded by nuclear genes and synthesized as larger precursors with amino-terminal amino acid extensions referred to as "pre-sequences" or "leader peptides" (reviewed in references 13 and 35) . These extensions, characterized by the presence of basic amino acid residues and the absence of acidic amino acids, are themselves sufficient to direct uptake of the precursor proteins into mitochondria (10, 16, 18, 27, 39) . Such uptake can occur posttranslationally (31) and often involves translocation across both the outer and inner membranes. Upon translocation, which requires an electrochemical potential across the inner mitochondrial membrane (7, 11, 19) and cytosolic nucleoside triphosphates (3, 9, 30) , the NH2-terminal extensions are processed by a chelator-sensitive protease(s) localized to the mitochondrial matrix (2, 5, (23) (24) (25) .
The biogenesis of ornithine transcarbamylase (OTC), ~ a
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mitochondrial matrix protein of the urea cycle, conforms to this model (reviewed in reference 33). OTC is encoded in the nucleus, synthesized on free polysomes as a larger precursor (pOTC) bearing an NH2-terminal leader peptide, and posttranslationally imported into mitochondria by a process requiting a mitochondrial membrane potential (4, 6, 19, 26) . Processing of pOTC to its mature form requires a zincdependent protease(s) localized to the mitochondrial matrix (5, (23) (24) (25) . Previous studies of posttranslational uptake of pOTC into isolated mitochondria have shown the production of an OTC species, designated iOTC, intermediate in size between pOTC and mature OTC (1, 19, 20, (22) (23) (24) (25) (26) (27) (28) . Some workers (1) have considered iOTC an in vitro artifact, while others (19, 25) have suggested that iOTC may represent a bonafide intermediate in the mitochondrial uptake pathway.
In this report, we present data showing that iOTC is formed within mitochondria during the course of normal biogenesis of OTC by a process that is dependent on a mitochondrial membrane potential, and is catalyzed by a mitochondrial matrix-localized protease. Further, using a tern-perature-shift protocol, we show unequivocally that iOTC is converted to OIC. To our knowledge, this is the first demonstration of such two-step cleavage for a matrix-localized mitochondrial enzyme. Finally, we have investigated the role of iOTC in the biogenesis of OTC by making amino acid substitutions in the leader peptide adjacent to the cleavage site that produces iOTC. Such substitutions abolish formation of both iOTC and OTC.
Materials and Methods

Materials
Restriction enzymes and other DNA-modifying enzymes were obtained from New England Biolabs (Beverly, MA 
Me~ods
Construction of Plasmids. An Xba I-Sac II fragment of rat pOTC eDNA pR021 (21) and a Sac II-Pst I fi'agment of pOTC-1 (17) were ligated with Xba I/Pst I-cut SP65 plasmid (Promnga Biotec). Subsequently, the full-length pOTC eDNA insert was isolated with minimal flanking sequence from SP65 by digestion with Msp I and inserted into the Ace I site in the polylinker region of pGEM2 (Promega Biotec). The A1-20 construct was generated by cutting out a BamH I-BamH I fragment from the full-length pOTC eDNA insert and ligating the remaining plasmid. This construct lacks the codon for the initiator methionine at position 1 of precursor OTC. Therefore, the peptide translated from an mRNA transcribed from this construct is initiated at the next inframe codon for methionine, i.e., the codon corresponding to amino acid 21 of pOTC. Mutant pOTC constructs encoding leader peptides that have the wild type arglnine residue at position 23 replaced with either glycine or aspartic acid were prepared by inserting a double-stranded oligonucleotide cassette (49 mer), with appropriately changed codons, between the unique Nco I site in the leader of pGEM-OTC and the Pvu II site at position 12 of mature OTC (21) . The constructs were subsequently sequenced by the method of Sanger et al. (34) to ensure that the desired changes were made.
In Vitro Transcription and Translation. For transcription from the SP6 promoter, the plasmid DNA was linearized with Hha I downstream from the T7 promoter. Lineafized plasmid DNA was then used in a transcription reaction containing 500 IxM nucleotide triphosphates, 1 lxCi [r 40 mM Tris-HC! (pH 7.5), 6 mM MgC12, 2 mM DTT, 30 U RNAsin, and 40 U SP6 polymerase. The reaction was carded out for 90 min at 40~ Aliquots of the transcription mixture were used directly in translation reactions. Cell-free translation using the rabbit reticulocyte lysate system was carried out as previously described (6) .
Incubation of Translation Mixture with Isolated Mitochondria and with Matrix Fraction. Mitochondria were isolated from rat liver as previously described (6) and diluted with 220 mM mannitol, 70 mM sucrose, 2 mM Hepes (pH 7.4) (HMS buffer) to 40 mg/ml total protein. Aliquots of the mitochondrial suspension (20 Ixl) were incubated with 20 ~tl of the translation mixture (final mitochondrial concentration 20 mg/mi) for 30 min at 27 or 2~ Products were then analyzed directly by SDS-PAGE as described (4) . When indicated, mitochondrial import mixtures were treated with trypsin (final concentration 40 Ixg/ml) for 10 min on ice and then supplemented with soybean trypsin inhibitor at a final concentration of 100 ~tg/ml. In some experiments, mitochondrial import mixtures were separated into supernataut and mitochondrial pellet by centrifugation in an Eppendorf microfuge (Brinkmann Instruments, Inc., Westhury, NY) for 5 rain. Supernatants were removed and analyzed directly by SDS-PAGE. Pellets were resuspended in mitochondrial isolation buffer (HMS) and then analyzed by SDS-PAGE. When indicated, 2,4-dinitrophenol (final concentrations indicated in figure legends) was added to 20 I.tl mitochondria (protein concentration 40 mg/ml) and the mixture incubated on ice for 10 min before the addition of an equal volume of pOIl2-containing translation mixture. When indicated, lanes were scanned with a scanning densitometer (Joyce, Loebl and Co. Ltd., Gateshead, England) and the peaks were integrated planimetricaily.
A mitochondrial matrix fraction was prepared as described by Conboy et al. (5) , diluted to 4 mg/ml protein concentration and supplemented with MnC12 and ZnC12 (0.1 mM final concentration). Wild type and mutant precursors synthesized in the reticulooyte lysate translation mixture were then added. When effect of prote.ase inhibitors was being studied, the translation mixture was supplemented with an equal volume of a 100,000 g supernatant of reticulooyte lysate containing the inhibitor before addition to the matrix fraction. Reaction mixtures were incubated for 60 min at 27~ at which time the reaction was stopped by addition of immunoprecipitation buffer (150 mM NaC1, 10 mM EDTA, 0.5% Triton X-100, 0.25% SDS, 2% methionine). Samples were then immunoprecipitated with anti-OTC antiserum and the immunoprecipitates analyzed by SDS-PAGE.
Oocyte Microinjection Experiments. Female Xenopus laevis were obtained from the African Xenopus Facility (Clareinch, Republic of South Africa), and were kept on a diet of beef liver and Nasco frog brittle (Nasco Biologicals, Fort Atkinson, WI). Stage V-VI oocytes (8) were freed of follicular tissue by manual dissection, and were maintained in OR-2 saline (40) containing penicillin (300 U/ml) and streptomycin (0.3 mg/ml) for injection and subsequent incubations. Groups of 12 oooytes were injected with •50 nl of translation mixture containing either pOTC or A1-20 pOTC. After incubation for 2 h at 19~ each group of cells was lysed in 500 Ixl 0.1 M NaCI, 1% Triton X-100, 0.1% SDS, 0.5% Na deoxycholate, and 0.01 M NaPO4, pH 7.4 (38) , supplemented with 1 mM PMSF, 1 gM pepstatin A, and 2 mM leupeptin (lysis buffer). Cell lysis was accomplished by repeatedly forcing the cells through a Pasteur pipette whose tip had been drawn out to a fine bore in a flame. The lysates were centrifuged for 5 min in an Eppendorf microfuge (Brinkrnann Instruments, Inc.) and the supernatants were immunoprecipitated as previously described (6) After 60 rain at 30~ reactions were cooled on ice, MnC12 and ZnCI2 were added to 0.1 mM, and a mitochondrial matrix fraction was added to a final concentration of 4 mg/mi matrix protein. Incubation was continued at 16oc for another 60 min. At that time, all labeled OI~ species were immunopt~cipi-tated with anti-OTC antiserum and the immune complexes were adsorbed with protein A-Sepharose. Adsorbed proteins were eluted by adding 3 vol of 125 mM Tris, pH 6.8, 2% SDS, and 5% [3-mercaptocthanol and heating for 3 min at 60~ The SDS buffer was diluted with 5 mM (NI-h)2HCO3, 0.01% Triton X-100 and the sample was concentrated using a centricon microfiltration device (Amicon Corp., Danvers, MA). Cold rat OTC protein (5 amoles) was added as carrier, and the protein was precipitated for 1 h on ice with 20% "IV_A. The acetone-washed pellet was suspended in 100% trifluoroacetic acid, immediately loaded on a gas-phase sequenator (Applied Biosystems, Inc., Foster City, CA) and subjected to automated Edman degradation. 90% of each cycle was used for scintillation counting, and 10% was taken out for ion-exchange HPLC of phenylthiohydantoin-amino acids. The first cycle yield from the carrier OTC was 20-40%; the yield from repetitive cycles was 90-95 %.
Results
1free Course of pOTC Import Suggests that iOTC Is an Intermediate
The time course of tK)TC internalization was examined by incubating isolated rat liver mitochondria with pOTCcontaining translation mixture at 27~ At each time point an aliquot of the import mixture was removed and the products analyzed by SDS-PAGE. As shown in Fig. 1 A, incubation of the pOTC-containing translation mixture (lane Tr) with mitochondria at 27~ leads to the conversion of pOTC into intermediate and mature-sized polypeptides. The amount of pOTC decreased steadily with time while the intensity of the mature OTC band increased steadily. Whereas no iOTC was detected at zero time, its intensity was maximal at 2 min of incubation and then decreased. Quantitation of this fluorograph by densitometric analysis is presented in Fig. 1 B. The observed kinetics are consistent with (but do not prove) a 
B o t h iOTC and M a t u r e OTC A r e Localized within Mitochondria
Previous results on the posttranslational import of pOTC into isolated mitochondria have been interpreted to suggest that either iOTC is a bonafide intermediate in OTC biogenesis (19) , or that iOTC is an artifact of the in vitro uptake systems (1) . To examine these two general possibilities, we incubated mitochondria with pOTC-containing translation mixture at 27~ for 60 min, then separated the mitochondrial import mixture into mitochondrial pellet and supernatant fractions, and analyzed each by SDS-PAGE. As seen in Fig. 2 A, lane T, iOTC and mature OTC were produced during the incubation at the expense of pOTC (lane Tr). When this import mixture was centrifuged, only pOTC was found in the supernatant fraction ( Fig. 2 A, lane S), while iOTC and OTC were found exclusively in the mitochondrial pellet (lane P) fraction. Some pOTC was recovered with the mitochondrial pellet as well; this could represent precursor either specifically bound to a surface receptor or nonspecifically adsorbed to the mitochondrial surface.
To determine the topology of iOTC, i.e., to test whether it is associated with the surface of the mitochondria or whether it has been translocated across the mitochondrial outer membrane, we tested its sensitivity to trypsin (Fig. 2  B) . Translation mixture (Fig. 2 B, lane Tr) containing pOTC (and a small amount of A1-20 band which arises in the cellfree translation mixtures as a result of variable initiation at the internal methionine at position 21) was incubated with mitochondria; the total import mixture was then treated with trypsin and analyzed by SDS-PAGE (lanes T). Trypsin treatment resulted in total degradation of pOTC (and A1-20) and almost complete recovery of both iOTC and mature OTC. These data indicate that iOTC represents a mitochondrially associated, trypsin-protected species.
As mentioned earlier, Argan et al. (1) have dismissed iOTC as a nonmitochondrial in vitro product generated either by a "leaked" mitochondrial matrix protease or a contaminating protease of some other origin. They have presented evidence that, in their hands, iOTC was not localized within heart mitochondria but rather was recovered in the supernatant fraction of an import mixture. We do not find this to be the case when rat liver mitochondria are used in the import reaction. Indeed, as shown in Fig. 2 , virtually all of the iOTC formed during a 60-rain incubation at 27~ was associated with the mitochondrial pellet and was protected from trypsin digestion, indicating localization within the organelle. Therefore, we posited that the discrepancy between our resuits and those of Argan et al. (1) might reflect differences in the intactness of mitochondria isolated from rat liver compared with those isolated from rat heart. It should be noted that preparation of heart mitochondria requires much longer homogenization of the tissue and hence could lead to production of more damaged mitochondria. To test this possibility, we exposed rat liver mitochondria to additional homogenization before using them in an import reaction. Such additional handling results in the isolation of mitochondria that leak, i.e., release some of their matrix content into the supernatant as evidenced by the release of significant amounts of mature OTC. Leaky mitochondria prepared in this way were incubated with translation mixture containing ptYl'C at 270C. At selected time points, an aliquot of the import mixture was taken and the products were analyzed by SDS-PAGE. The results are shown in OTC is significantly delayed and reduced in the damaged mitochondria. The kinetics of iOTC appearance also show a dramatic difference: in "healthy" mitochondria ( Fig. 1 A) iOTC appearance shows a discrete early peak; in leaky ones (Fig. 3 A) , iOTC rises almost linearly with time from 0 to 20 rain of incubation. The latter kinetics would be expected if pOTC was being cleaved in the supernatant by a released matrix protease. To test this hypothesis further, we incubated damaged mitochondria with pOTC-containing translation mixture at 27~ for 60 rain and then separated the import mixture into supernatant and mitochondrial fractions. As shown in Fig. 3 B, lane T, iO'IC and OTC were generated during the incubation. Upon separation, the majority of iOTC was recovered in the supernatant, the majority of OTC was recovered in the pellet, and pOTC was present in both fractions. After trypsin treatment, pOIC, iOTC, and ~ in the supernatant were completely degraded, while, in the pellet, some iOTC and OTC were protected but pOTC was not.
Based on these data, we conclude that the intermediatesized OTC species produced by damaged mitochondria is, indeed, produced by a protease released from mitochondria and is not related to import. However, our data (Fig. 2) clearly show that under our conditions of import, the amount of such extramitochondrial iOTC produced is so low as to be undetectable, and that the iOTC which we observe is a mitochondrially located form.
Formation of iOTC Requires an Intact Mitochondrial Membrane Potential
Normal uptake of pOTC (as measured by formation of mature OTC) requires an intact mitochondrial membrane potential (19, 26) . To test whether iOTC formation depends on the same uptake mechanism as formation of OTC, we incubated pOTC-containing translation mixture with mitochondria that had been treated with the uncoupler, DNP. In the presence of DNP, the electrochemical gradient across the mitochondrial inner membrane collapses, and ATP is degraded as the Figure 4 . DNP inhibits formation of iOTC. DNP was added to isolated mitochondria at a concentration of 50 or 1130 gM. After 10 min on ice, pOTC-containing translation mixture was added and the import mixture incubated at 27~ for 30 min. Mitochondria were isolated by centrifugation and analyzed by SDS-PAGE. Lane 1, no DNP; lane 2, 50 taM DNP; lane 3, I00 taM DNP. mitochondrial membrane ATPase is uncoupled from electron transport. In the presence of 50 or 100 laM DNP (Fig.  4, lanes 2 and 3, respectively) , production of both iOTC and OTC was inhibited. This is further evidence that iOTC is formed during the course of normal uptake of pOTC into mitochondria because uncoupling of mitochondria in the in vitro uptake reaction should have no effect on the action of an extramitochondrial protease. In the presence of DNP, only small amounts of pOTC were recovered with the mitochondria (most of the input pOTC was present in the supernatant of an import mixture) and probably represents pOTC nonspecifically bound to the mitochondrial surface. This suggestion is based on our results (data not shown) that DNP prevents binding of pOTC to mitochondria in vivo. Trypsin treatment of a DNP-blocked import mixture led to complete degradation of pUIX2 (data not shown). 1 mM) , and 100,000 g supernatant of reticulocyte lysate containing specific inhibitor. Mitochondrial matrix fraction was added to 4 mg/ml final protein concentration, and the mixture was incubated at 27~ for 60 min (lanes 3-8) as to whether iOTC is a direct precursor of OTC. Mitochondria were incubated with pOTC-containing translation mixture for 30 min at 16~ Treatment of this import mixture with trypsin led to the complete disappearance of pOTC (Fig.  5, lane 2) . Subsequent incubation of this reaction mixture at 27~ led to a marked decrease in the intensity of the iOTC band with a concurrent and parallel increase in the intensity of OTC (Fig. 5, lane 3) . Densitometric quantitation of lanes 2 and 3 (shown below the gel in Fig. 5 ) reveals that iOTC is converted to OTC with •50% efficiency. These results show that iOTC is a direct precursor of OTC.
A Mitochondrial Matrix Fraction Cleaves pOTC to iOTC
To further characterize the pOTC to iOTC cleavage, we incubated pOTC with an isolated mitoehondrial matrix fraction, prepared as described by Conboy et al. (5) . The matrix fraction cleaved pOTC to both iOTC and OTC (Fig. 5, lanes  2 and 3) . In an attempt to selectively inhibit iOTC formation, we tested a number of protease inhibitors for their effect on the matrix-catalyzed cleavage. The protease inhibitor pepstatin A (1 mg/ml) and the chelating agent 1,10-phenanthroline (5 mM), each inhibited formation of mature OTC without substantially inhibiting iOTC formation (Fig. 6 , lanes 5 and 6). Leupeptin (2 mg/ml) reduced formation of both iOTC and OTC (Fig. 6, lane 4) , while rhodamine 613 and ATP depletion had no effect (Fig. 6, lanes 7 and 8) . Significantly, we did not find an inhibitor that specifically inhibited production of iOTC while allowing OTC production. Because we could build up intermediate under conditions (16~ incubation) in which little OTC was produced (Fig. 6, lane  2) , we used this system to produce sufficient iOTC to define the sequence of the NH2 terminus of the iOTC peptide.
iOTC Is Produced by Cleavage within the pOTC Leader Sequence
To establish that the apparent difference in molecular weight between iOTC and either pOTC or mature OTC reflects cleavage of a part of the pOTC leader and not some modification merely altering electrophoretic mobility on SDS-PAGE, we sequenced the amino terminus of iOTC. Precursor OTC was synthesized in a reticulocyte lysate in the presence of [3H]tyrosine or [3H]proline. The translation mixture was incubated with a mitochondrial matrix fraction at 16~ (under conditions which favor iOTC production) and then immunoprecipitated with anti-OTC antiserum. The immunoprecipitated material was eluted from protein A-Sepharose, dialyzed, and subjected to automated Edman degradation (Fig. 7). [3H]Tyrosine and [3H]proline were chosen because these amino acids are found in the region of the pOTC leader expected to be retained in iOTC. Importantly, they are not found in the amino-terminal portion of the leader; thus, no label would be released from any residual pOTC in the immunoprecipitate. Radioactivity released during Edman degradation of [3H]tyrosine-labeled material was detected in cycle 3; when material was radiolabeled with [3H]proline, radioactivity was detected in cycle 6. The numbering of each cycle of Edman degradation was checked by analyzing amino acids released during each cycle from carrier mature OTC and comparing them with the sequence of mature OTC. In the cycle in which [3H]tyrosine was released, cold valine was detected and in the cycle containing [3H]proline, cold lysine was present. Comparison with the amino acid sequence deduced from the eDNA sequence (21; see Fig. 7 ) shows, therefore, that the cleavage site used in production of iOTC is between residues 24 (asparagine) and 25 (phenylalanine) of the leader.
iOTC Is Formed In Vivo
The data presented thus far define parameters ofiOTC formation and conversion to OTC by isolated rat liver mitochondria. To eliminate the possibility that generation of iOTC represents an artifactual (but mitochondrial) cleavage due to the disruption of mitochondria during their isolation, we examined the import of rat pOTC in an intact cell, i.e., in the frog oocyte. This experimental system eliminates the possible mitochondrial damage which might occur during liver homogenization and fractionation. Translation mixtures containing either p(YI~ or A1-20 pOTC were injected into oocytes. Since A1-20 ~ is neither taken up by rat liver mitochondria nor cleaved (22; and Fig. 2 ), this mutant polypeptide acts as a control in the oocyte system. After injection, the cells were incubated for 120 min at 19~ and then lysed by addition of lysis buffer (see Materials and Methods) containing protease inhibitors. The lysates were immunoprecipitated and analyzed by SDS-PAGE. As shown in Fig. 8 
Mutations Introduced Adjacent to iOTC Cleavage Site Abolish Production of Normal iOTC and OTC
As a further test of the importance of iOTC in the production of OTC, we attempted to disrupt the cleavage site between position 24 and 25 by introducing novel amino acids into the pOTC sequence. We chose as our target the arginine at position 23 of the leader for several reasons: (a) an abundance of arginine residues is the one common feature of all mitochondrial leader peptides sequenced thus far; (b) while characterizing a partially purified, leader peptide-cleaving mitochondrial protease, Miura et al. (23) suggested that most leaders that are cleaved by a chelator-sensitive matrix protease have a basic amino acid residue at position -2 or -3 relative to the cleavage site; and (c) substitution of a glycine for arginine 23 of the human pOTC leader abolishes cleavage of that precursor to mature OTC (15) .
The arginine at position 23 of the rat ~ leader was changed to either glycine or aspartic acid by standard methods of in vitro site-directed mutagenesis. The mutant precursors were synthesized in the rabbit reticulocyte lysate system, and the translation products were incubated with isolated mitochondria. As shown in Fig. 9 A, both precursors were cleaved to a novel OTC species, whose gel mobility was intermediate between pOTC and the "A1-20" band. In the case of the asp 23 substitution, the novel cleaved form was the only "new" product detected after incubation of the mutant precursor with mitochondria. Whereas the novel cleavage product was also the predominant product formed from the gly 23 mutant precursor, longer exposures of the fluorograph revealed weak bands corresponding to iOTC and OTC. Since inhibition of OTC production corresponds in each case with inhibition of iOTC production, we conclude that the production of OTC is tightly linked to the production of iOTC.
The Novel Cleavage Form Is the Product of Mitochondrial Import and a Matrix Protease
We incubated both the asp 23 and the gly 23 mutant precursors with isolated mitochondria to establish whether the formation of the novel cleavage products reflected import of the mutant precursor and cleavage by a matrix protease. Because analogous results were obtained for asp 23 and gly 23 mu- tants, only the data for asp 23 are shown. Asp 23 pOTC-conraining translation mixture was incubated with mitochondria ( Fig. 9 B, lane 3) and then proteinase K was added to the reaction mixture (Fig. 9 B, lane 4) . As expected for an imported protein, the new product is protected from externally added protease, while most of the precursor and the unimportable A1-20 are degraded.
The results of incubation of asp 23 precursor with mitochondria in the presence of DNP are presented in Fig. 9 B, lane 2. No cleavage to the novel product was observed in the presence of inhibitor, as would be expected if cleavage follows the normal uptake which is dependent on a mitochondrial membrane potential.
To further characterize the cleavage of the mutant rat precursors, we incubated asp 23 and gly 23 pOTCs with a soluble matrix fraction from rat liver mitochondria. As shown in Fig. 9 C, asp 23 precursor was cleaved by the soluble matrix fraction to a product migrating with mobility identical to the product seen after incubation with intact mitochondria. Analogous results were obtained for gly 23 pOTC (data not shown).
Identification of the "Cryptic" Cleavage Site
Because we were interested in the novel cleavage site that is used in the gly 23-and asp 23-substituted rat OTC precursors, we used the matrix fraction to prepare [~H] Fig. 9 C, the radiolabeled proteins were prepared for sequencing as described in Materials and Methods and subjected to Edman degradation. material was recovered in cycles 1 and 5. This maps the asp 23 novel cleavage site between residues 16 and 17 of the pOTC leader. The methionine label released in cycle 1 is from the pOTC and A1-20 which remain in the sequenced sample (see Fig. 9 C for an example of the material that was sequenced). We have also determined that the major product formed during incubation of gly 23 substituted pOTC with mitochondria is cleaved between residues 16 and 17 (data not shown).
D i s c u s s i o n
During the nearly ten years that the biogenesis of OTC has been investigated, a rat OTC species (iOTC) intermediate in size between the precursor and the mature form of OTC has been observed repeatedly in this and in a number of other laboratories. The precise significance of this molecule, however, has not been defined. While some (19, 25) have proposed that iOTC represents a bona fide intermediate in the mitochondrial import pathway of OTC, others (1) have concluded that the appearance of iOTC is due to artifactual cleavage of pOTC and is not part of the physiologic pathway of mitochondrial import and cleavage. In this report we present data that define iOTC as a true intermediate in the mitochondrial import pathway of OTC. This conclusion is based upon the following findings: (a) iOTC produced in an import reaction containing undamaged mitochondria is recovered in the mitochondrial pellet; (b) iOTC produced at 27~ is trypsin protected, suggesting intramitochondrial localization; (c) iOTC can be converted directly to mature OTC; (d) iOTC is not produced in the presence of an uncoupler of oxidative phosphorylation, indicating that cleavage occurs only after pOTC is internalized by mitochondria; (e) iOTC is produced in intact cells, thereby excluding the possibility that its appearance is due to damaged mitochondria or to some other artifact inherent in the in vitro protocols; and (f) substitutions near the iOTC cleavage site inhibit formation of both iUYC and mature OTC.
The production of intermediates in the biogenesis of mitochondrial enzymes has been noted before. Partially cleaved forms of yeast cytochrome b2 (29, 32 ) (a soluble enzyme of the intermembrane space), cytochrome c~ of yeast (12, 29) and Neurospora (36) , Fe/S protein of ubiquinol-cytochrome c reductase (14) (proteins located in the inner membrane and exposed to the intermembrane space), and ATPase subunit 9 (37) (inner membrane protein) have been demonstrated in vitro and in vivo. These precursors are first cleaved within the leader to an intermediate form by a matrix-located protease, then cleaved again by a protease located either in the matrix (37) or in the intermembrane space (29, 32) . The twostep processing which has been described for the precursors of yeast cytochrome b2 and the Fe/S protein of Neurospora has been shown to be important in determining the subrnitochondrial localization of these enzymes. After translocation, cytochrome b2 precursor is cleaved to produce an intermediate containing a domain spanning the inner mitochondrial membrane and majority of the protein protruding into the intermembrane space. In the second cleavage step, the membrane domain is removed, resulting in the release of soluble enzyme into the intermembrane space. The Fe/S protein precursor is translocated entirely into the matrix where the extreme NH2 terminus of the leader peptide is cleaved. A remaining hydrophobic portion of the leader peptide then acts as a "signal peptide" and directs the transfer of the mature portion of the protein back across the inner membrane. Once transfer is complete, a protease located outside the inner mitochondrial membrane removes the remaining portion of the leader.
To our knowledge this is the first report describing a matrix enzyme precursor that is cleaved twice during its biogenesis. Why a second cleavage event has evolved (or persisted) in the biogenesis of OTC is unclear. Since both cleavage events occur in the mitochondrial matrix, the portion of the leader peptide left on iOTC is probably not a submitochondrial sorting signal. In the absence of an obvious role for twostep proteolysis of pOTC, we are considering three different models for the process: (a) Possibly the observation of iOTC cleavage as a distinct step in leader peptide removal merely reflects an unusually slow step in what is usually (for other precursors) a rapid concerted series of leader peptide cleavages. Supporting this notion of processive proteolysis is the observation that during in vitro import of the human OTC precursor, iO'lE is an extremely short-lived species (data not shown). We have shown that certain amino acid substitutions in the rat pOq~ leader adjacent to the iOTC cleavage site inhibit formation of iOTC and mature OTC. These substitutions allow translocation of the altered precursors but lead to a formation of a novel form of OTC cleaved between residues 16 and 17 of the leader. In a recent paper, Nguyen et al. (28) have shown that deletion of residues 22-30 of this same precursor has similar effects: translocation of the altered precursor without cleavage to mature OTC, and inefficient cleavage of the translocated precursor at a new site within the leader peptide.
Several explanations for the effect of position 23 substitution and deletion of position 23 on formation of mature OI~ can be put forward. If iOTC is an obligate precursor to OTC, then interfering with iOTC cleavage would also inhibit OTC production. Alternatively, the critical peptide structure determined by arginine 23 may present both iO'IE and OTC cleavage sites to the active site or sites of one or more matrix proteases. In this second case, the critical conformation must be held intact after removal of amino acid residues 1-24, because we have clearly demonstrated that iOI~ formed in isolated mitochondria can be cleaved to Oil. Each of the above models makes specific predictions regarding the number and specificities of mitochondrial matrix proteases. We are currently isolating the protease responsible for each of the steps of pOTC conversion to OTC in order to define whether formation of iO'lC is an obligatory step in O1"I2 production.
